Literature DB >> 3591424

Midwinter insomnia in the subarctic region: evening levels of serum melatonin and cortisol before and after treatment with bright artificial light.

T Hansen, T Bratlid, O Lingjärde, T Brenn.   

Abstract

"Midwinter insomnia" (MI), mainly characterized by difficulties in falling asleep at night, is a common complaint during the period of obscuration or "dark period" north of the arctic circle. We hypothesize that MI is a result of a phase delay of the sleep-wake cycle due to insufficient exposure to daylight. In the present study based on this hypothesis, we wanted to find out whether otherwise healthy subjects with MI show abnormalities in the endocrine markers melatonin and cortisol late in the evening, and whether exposure to intensive light for one half hour in the morning for 5 days has any effect on the insomnia and on the endocrine variables. Nine subjects with typical MI were compared to eight controls. Before light exposure, the MI group had a significantly lower level of plasma melatonin in the evening than the controls, and a nonsignificant increase of plasma cortisol. After light exposure, the following results were seen in the MI group: sleep latency was moderately but significantly shortened, plasma melatonin increased to the same level as in the controls, and there was a nonsignificant increase of plasma cortisol. These results are largely in accordance with the predictions made from the phase delay hypothesis. However, other explanations cannot be ruled out.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3591424     DOI: 10.1111/j.1600-0447.1987.tb02811.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  6 in total

1.  Hypothalamic involvement in chronic migraine.

Authors:  M F Peres; M Sanchez del Rio; M L Seabra; S Tufik; J Abucham; J Cipolla-Neto; S D Silberstein; E Zukerman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-12       Impact factor: 10.154

2.  Neuroendocrine Profile in the Night Eating Syndrome.

Authors:  Grethe Støa Birketvedt; Allan Geliebter; Jon Florholmen; Marci E Gluck
Journal:  Curr Obes Rep       Date:  2014-03

3.  Effects of Daytime Exposure to Light from Blue-Enriched Light-Emitting Diodes on the Nighttime Melatonin Amplitude and Circadian Regulation of Rodent Metabolism and Physiology.

Authors:  Robert T Dauchy; Melissa A Wren-Dail; Aaron E Hoffman; John P Hanifin; Benjamin Warfield; George C Brainard; Steven M Hill; Victoria P Belancio; Erin M Dauchy; David E Blask
Journal:  Comp Med       Date:  2016       Impact factor: 0.982

4.  Daytime Blue Light Enhances the Nighttime Circadian Melatonin Inhibition of Human Prostate Cancer Growth.

Authors:  Robert T Dauchy; Aaron E Hoffman; Melissa A Wren-Dail; John P Hanifin; Benjamin Warfield; George C Brainard; Shulin Xiang; Lin Yuan; Steven M Hill; Victoria P Belancio; Erin M Dauchy; Kara Smith; David E Blask
Journal:  Comp Med       Date:  2015-12       Impact factor: 0.982

Review 5.  Biological rhythms during residence in polar regions.

Authors:  Josephine Arendt
Journal:  Chronobiol Int       Date:  2012-04-12       Impact factor: 2.877

6.  Chronic artificial blue-enriched white light is an effective countermeasure to delayed circadian phase and neurobehavioral decrements.

Authors:  Raymond P Najjar; Luzian Wolf; Jacques Taillard; Luc J M Schlangen; Alex Salam; Christian Cajochen; Claude Gronfier
Journal:  PLoS One       Date:  2014-07-29       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.